Are you a Business Owner?
Set up your Private Seller Account and create your listing todayGet Started Here
The company has developed a precision Neuronal Response Time measurement device that will revolutionize diagnostic and therapeutic delivery for the Neurological and Cognitive Health markets. The device is easily administered, non-invasive, and provides an early warning of the onset of disease by providing accurate and repeatable measurement of a patient’s decline in neurological performance. Patients suffering from Alzheimer’s, dementia, concussions, other TBI’s, strokes, and learning disabilities will benefit from the use of this device. This product has applications in multiple markets, including medical, sports, education and defense. The company currently has one patent issued, two domestic and international patents pending and several more in process.
The expected revenue based on 0.1% of market penetration is $176,671,430 and if you base the revenue on 5% of market penetration the figure is $8,833,571,931.
Can be anywhere
Company will go public in future
ImPACT as a standard NP test, Static and dynamic balance testing, Measuring changes in simple reaction time,Virtual reality to detect attention deficits, Sport Concussion Assessment Tool (SCAT2),
King-Devick test, Montreal Cognitive Assessment (MOCA), Mini-Mental State Examination (MMSE)
The company is asking for investors to be a part of the device’s continuing development and it’s adoption into the market.
If you own a business and are considering selling, visit our Sell a Business section. Limited Free Trial available.Sell Your Business